Omics of Hereditary Breast Cancer

作者: Catherine A. Moroski-Erkul , Burak Yilmaz , Esra Gunduz , Mehmet Gunduz

DOI: 10.1007/978-81-322-0843-3_2

关键词:

摘要: Breast cancer is the leading cause of cancer-related deaths among women worldwide. Although advances in our understanding this disease have been made last decade, available treatments remain inadequate, particularly for more intractable forms breast cancer. Hereditary or familial poses a difficult challenge as only few susceptibility genes with high penetrance identified, namely, BRCA1 and BRCA2. It now suspected that majority hereditary cancers are caused by various combinations several moderate- and/or low-penetrance genes. Recent developments research methodologies conceptual frameworks within biology revolutionized study This systems approach, which emphasizes holistic biological systems, referred to generally “omics.” A decade omics has led identification many new therapeutic targets biomarkers, allowing accurate earlier diagnosis treatment wide spectrum diseases collectively Here we review contributions fields cancer, genomics, transcriptomics, proteomics, metabolomics.

参考文章(189)
L Pignataro, D Pagani, G Pruneri, G Sambataro, Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review. Acta Otorhinolaryngologica Italica. ,vol. 25, pp. 75- 85 ,(2005)
Gabriela Riscuta, Ramona G. Dumitrescu, Nutrigenomics: Implications for Breast and Colon Cancer Prevention Methods of Molecular Biology. ,vol. 863, pp. 343- 358 ,(2012) , 10.1007/978-1-61779-612-8_22
Christopher S. Poultney, Alex Greenfield, Richard Bonneau, Integrated inference and analysis of regulatory networks from multi-level measurements. Methods in Cell Biology. ,vol. 110, pp. 19- 56 ,(2012) , 10.1016/B978-0-12-388403-9.00002-3
Douglas Hanahan, Robert A. Weinberg, Hallmarks of cancer: the next generation. Cell. ,vol. 144, pp. 646- 674 ,(2011) , 10.1016/J.CELL.2011.02.013
P. J. Verschure, M. G. Rots, M. L. de Groote, Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes Nucleic Acids Research. ,vol. 40, pp. 10596- 10613 ,(2012) , 10.1093/NAR/GKS863
Wen Wang, Lan-Juan Zhao, Ye-Xiong Tan, Hao Ren, Zhong-Tian Qi, MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma Carcinogenesis. ,vol. 33, pp. 1113- 1120 ,(2012) , 10.1093/CARCIN/BGS113
Birgitte Smith-Sørensen, Lars Ottestad, Eivind Hovig, Jorunn Eyfjörd, Noële Barbier-Piraux, Noële Barbier-Piraux, Stephen H. Friend, Stephen H. Friend, Steinunn Thorlacius, Tone Ikdahl Andersen, Judy Garber, David Malkin, David Malkin, Anne Lise Børresen, Screening for germ line TP53 mutations in breast cancer patients. Cancer Research. ,vol. 52, pp. 3234- 3236 ,(1992)
Päivi Östling, Suvi-Katri Leivonen, Anna Aakula, Pekka Kohonen, Rami Mäkelä, Zandra Hagman, Anders Edsjö, Sara Kangaspeska, Henrik Edgren, Daniel Nicorici, Anders Bjartell, Yvonne Ceder, Merja Perälä, Olli Kallioniemi, Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells. Cancer Research. ,vol. 71, pp. 1956- 1967 ,(2011) , 10.1158/0008-5472.CAN-10-2421
Tom Walsh, Silvia Casadei, Kathryn Hale Coats, Elizabeth Swisher, Sunday M. Stray, Jake Higgins, Kevin C. Roach, Jessica Mandell, Ming K. Lee, Sona Ciernikova, Lenka Foretova, Pavel Soucek, Mary-Claire King, Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. ,vol. 295, pp. 1379- 1388 ,(2006) , 10.1001/JAMA.295.12.1379
M. L. Gatza, J. E. Lucas, W. T. Barry, J. W. Kim, Q. Wang, M. D. Crawford, M. B. Datto, M. Kelley, B. Mathey-Prevot, A. Potti, J. R. Nevins, A pathway-based classification of human breast cancer Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 6994- 6999 ,(2010) , 10.1073/PNAS.0912708107